Alkyl Amines Chemicals (506767) Q2 25/26 earnings summary

Executive summary

• First half of FY 2026 saw subdued demand, marginal volume growth, and flat revenue due to lower prices, with profitability maintained through margin management despite global pressures.

• Revenue from operations for Q2 FY26 was ₹405.53 crore, with total revenue at ₹413.49 crore, slightly down from ₹424.05 crore in Q2 FY25.

• Net profit after tax for Q2 FY26 was ₹49.44 crore, compared to ₹47.46 crore in Q2 FY25.

• Geopolitical actions, especially U.S. sanctions, impacted exports, customer demand, domestic competition, and supply chains.

• Total comprehensive income for Q2 FY26 was ₹49.43 crore, marginally higher than ₹46.46 crore in Q2 FY25.

Financial highlights

• Volumes were slightly higher year-over-year, but top-line growth was flat due to subdued pricing.

• Gross margins and overall contribution remained stable despite lower selling prices, especially in ethylamines.

• Operating profit before tax for H1 FY26 was ₹125.45 crore, down from ₹130.24 crore in H1 FY25.

• Cash flow from operating activities for H1 FY26 was ₹75.48 crore, significantly lower than ₹163.55 crore in H1 FY25.

• Dividend paid during H1 FY26 was ₹51.14 crore.

Outlook and guidance

• Volume growth for FY 2026 is expected to remain subdued, below the typical 7–15% range, due to ongoing market challenges.

• Benefits from anti-dumping duties on isopropylamine are expected to materialize from Q4 onwards, improving both prices and volumes.

• New product (DMC) commercialization is targeted for Q1 FY 2027, with expectations of strong profitability and import substitution.

• Financial results have been reviewed and approved by the Audit Committee and Board, with an unmodified limited review report from statutory auditors.